The nationally recognized rating service Super Lawyers has released its list of 2021 N.Y. Metro Rising Stars. Eleven of those attorneys work for Weitz &…
Read MoreFirm News: Drugs & Devices: Page 6
Category: Drugs & Devices
W&L Accepting Homeopathic Teething Product Injury Cases
Weitz & Luxenberg is now accepting cases of children or infants who were injured after using homeopathic teething tablets and gels produced by Hyland’s…
Category: Drugs & Devices
FDA Reviewing SGLT2 Inhibitors and Acute Pancreatitis Reports
Updated September 14, 2017. Following reports of acute pancreatitis among people taking a type of diabetes medication, the U.S. Food and Drug Administration (FDA)…
Category: Drugs & Devices
Danielle Gold Speaks on Stryker LFIT V40 Litigation at AAJ Mass Torts Seminar
Danielle Gold, an associate attorney in Weitz & Luxenberg’s Drug and Medical Device Litigation group, will participate in a discussion on Stryker’s LFIT V40…
Category: Drugs & Devices
Onglyza & Kombiglyze XR
Onglyza and Kombiglyze XR are approved for use with diet and exercise to control blood sugar in adults with type 2 diabetes. Results from…
Category: Drugs & Devices
W&L Investigates Rising Costs of Insulin
Weitz & Luxenberg is investigating the pricing of insulin by three major drug companies — Eli Lilly, Novo Nordisk, and Sanofi — following a…